Dr. Theresa Callard-Moore discusses how cancer treatment and transplant can affect sexual health, intimacy, and relationships. She covers common physical and emotional challenges and offers practical strategies for communication, rebuilding intimacy, managing discomfort, and getting support from the healthcare team.

This presentation reviews the latest advances in preventing and treating acute and chronic graft-versus-host disease (GVHD). Dr. Cutler discusses how post-transplant cyclophosphamide (PTCy) has changed GVHD prevention, new treatments for chronic GVHD, and research on combination therapies and early intervention. He also answers questions about clinical trials, treatment duration, and GVHD’s relationship to relapse.

Graft-versus-host disease (GVHD) is a potential complication after a bone marrow/stem cell transplant using donor cells. This presentation explains what GVHD (GVHD) is, the difference between acute and chronic GVHD, risk factors for developing GVHD, how to monitor yourself to catch and report symptoms early, treatment options, and lifestyle changes that can improve GVHD symptoms.

In this session, leading experts on graft-versus-host disease (GVHD), a common complication after a bone marrow/stem cell transplant, respond to questions about who is at risk of developing GVHD, symptoms of GVHD, and how to manage both the physical and emotional problems associated with GVHD and its treatment.

Graft-versus-host-disease (GVHD) can be a major complication after bone marrow/stem cell transplantation. This presentation describes the types of GVHD, its typical effects on patients, and several promising new treatments for this condition.

Graft-versus-host-disease (GVHD) can be a significant problem after stem cell transplantation. This presentation discusses what GVHD is, risk factors for developing it and recent advances in the prevention and treatment of GVHD.

Graft-versus-host disease (GVHD) is a common complication after a stem cell transplant. Extracorporeal photopheresis (ECP) can be an effective treatment for certain types of GVHD. This presentation explains how ECP works and its potential benefits for patients with significant GVHD.

Graft-versus-host disease (GVHD) is a common complication after a bone marrow/stem cell transplant using donor cells (allogeneic transplant). This presentation will discuss current techniques to prevent GVHD, new drugs to treat acute and chronic GVHD and clinical trials testing new GVHD therapies.

Graft versus Host Disease (GVHD) is a common complication after allogeneic stem cell transplant. Learn the difference between acute and chronic GVHD and how each develops. Both standard therapies and exciting new prevention and treatment interventions are discussed.

The overall health of the gut microbiome and its organisms can influence the prevalence and severity of graft-versus-host disease. This presentation reviews the causes and mechanisms of how organisms in the gut can affect GVHD and reviews potential strategies to minimize this problem.